[1]
Qureshi, S. et al. 2026. Comparative Efficacy of Resmetirom, GLP-1 Receptor Agonists, and Pioglitazone for Fibrosis Regression and MASH Resolution in Metabolic Dysfunction-Associated Steatohepatitis: A Systematic Review and Narrative Synthesis of Network Meta-Analyses with Implications for Pakistan. Pakistan Journal of Gastroenterology. 42, 2 (Aug. 2026), 911–913. DOI:https://doi.org/10.63521/641kea29.